Basic Information
Vizarsin
Regulatory Information
EMEA/H/C/001076
Authorised
September 21, 2009
June 25, 2009
19
February 23, 2023
Company Information
Slovenia
Šmarješka cesta 6 8501 Novo mesto
KRKA, d.d., Novo mesto
Drug Classification
Generic Medicine
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Vizarsin to be effective, sexual stimulation is required.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Vizarsin. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Vizarsin.